Dr. Dhodapkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
- Seth G.S. Medical CollegeClass of 1991
- University of TennesseeFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- GA State Medical License 2018 - 2025
- CT State Medical License 2008 - 2018
- NY State Medical License 1998 - 2011
- AR State Medical License 1995 - 1999
- MN State Medical License 1993 - 1996
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy Start of enrollment: 2019 Jun 05
Publications & Presentations
PubMed
- Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis
NPJ Vaccines. 2024-10-27 - Minority report on cancer immunotherapy: focus on elderly and other understudied populations.Kavita Dhodapkar, Johanneke Portielje
Journal for Immunotherapy of Cancer. 2024-10-26 - 1 citationsClinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial.Shambavi Richard, Alexander M Lesokhin, Barry Paul, Jonathan L Kaufman, Matthew Pianko
Nature Cancer. 2024-10-01
Press Mentions
- Specific Components of the Tumor Immune Microenvironment May Affect the Durability of Responses to BCMA CAR T-cell TherapyAugust 29th, 2022
- Immune Cell Changes Detected in Waldenstrom Macroglobulinemia (WM)September 2nd, 2021
Grant Support
- Fcgamma Mediated Regulation Of Dendritic Cell FunctionNational Institute Of Allergy And Infectious Diseases2009–2011
- Immune Resistance To Glioma VIA Dendritic CellsNational Institute Of Allergy And Infectious Diseases2008
- Immune Resistance To Glioma VIA Dendritic CellsNational Institute Of Allergy And Infectious Diseases2004–2007
- Antitumor Immune Response In Patients With Primary Brain TumorsNational Center For Research Resources2005
- Antitumor Immue Response In Patients With Primary Brain TumorsNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: